by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) — Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis, today...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet need, today...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SAN JOSE, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Apigee® (NASDAQ:APIC), the API company, today announced financial results for its fourth quarter and fiscal year ended July 31, 2016. Fiscal Year 2016 For FY 16, Apigee reported total revenue of $92.0 million,...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Immune Design Corp. (Nasdaq:IMDZ) announced today that it plans to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the proposed offering...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
DALLAS, Sept. 14, 2016 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (the “Company”) (Nasdaq:BLDR), a leading supplier and manufacturer of structural and related building products for residential new construction and home repair and remodeling in the United...